Theoretical Framework for Nanobots in Future Biomedical Applications: Intravascular Surveillance Nanobot (ISN-01)
Modern clinical practice remains predominantly post-symptomatic, intervening only after irreversible tissue damage or acute physiological collapse has already occurred. This theoretical framework introduces the Intravascular Surveillance Nanobot (ISN-01), an autonomous, circulating nanorobotic biosurveillance platform modeled on erythrocyte hemodynamics. Designed with a biconcave discoid morphology and cloaked in a biomimetic CD47-functionalized membrane to prevent macrophage phagocytosis and the Vroman effect, the platform achieves a target 120-day physiological surveillance lifespan. The device incorporates multiplexed graphene field-effect transistor (GFET) biosensing arrays for subclinical picomolar detection of acute cardiovascular collapse markers (cardiac troponin I and h-FABP) alongside early hyperinflammatory septic cascades (lipopolysaccharides, procalcitonin, and IL-6). Acoustic sub-dermal telemetry (1–5 MHz) transmits emergency alerts directly through cutaneous capillary beds to consumer wearable smart devices. Programmed hydrolytic breakdown of the cross-linked poly(lactic-co-glycolic acid) (PLGA) chassis ensures safe, non-toxic elimination via renal glomerular filtration (<8 nm) and hepatobiliary clearance. Released under a Creative Commons Attribution 4.0 International license, this open-source architecture aims to democratize continuous early-warning health defense as a universal public good.
Authors
- Krishna sumanth Kallu
- Zaheer khalander Sheik
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.5281/zenodo.24212883
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- preprint